Short answer

When designing for postmenopausal women, consider that hormonal changes can impact physiological parameters like blood pressure and arterial stiffness, potentially influencing user responses to products and environments.

Field: Human Factors
Source: Hypertension (2009)
Method: Cross-sectional study
Sample: 76 participants
Evidence: Moderate effect

Higher prolactin serum levels in postmenopausal women are associated with increased central blood pressure and arterial stiffness, independent of traditional cardiovascular risk factors. This human factors research insight is drawn from a 2009 study published in Hypertension. Using Cross-sectional study with 76 participants, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing for postmenopausal women, consider that hormonal changes can impact physiological parameters like blood pressure and arterial stiffness, potentially influencing user responses to products and environments.

Study

Human FactorsHigh ImpactModerate effect

Elevated Prolactin Levels Correlate with Increased Arterial Stiffness in Postmenopausal Women

Higher prolactin serum levels in postmenopausal women are associated with increased central blood pressure and arterial stiffness, independent of traditional cardiovascular risk factors.

Hypertension · 2009

Key Findings

01Positive correlations were found between prolactin serum levels and arterial blood pressure, central aortic systolic and diastolic blood pressures, and pulse wave velocity (a marker of aortic stiffness).
02Prolactin levels independently predicted blood pressures and aortic stiffness, even after accounting for traditional risk factors.
03Prolactin levels correlated with the European Society of Cardiology HeartScore, a composite index predicting 10-year cardiovascular mortality.
04No correlation was observed with endothelial or microcirculatory function or carotid intima-media thickness.

Application

Design takeaway

How to apply

When designing health-related technologies or interventions for women in or past menopause, consider how factors like prolactin levels might influence user health outcomes and product efficacy.

Project actions

01When researching user groups, consider physiological factors that change with age or hormonal status.
02If your design involves health monitoring or interventions, investigate relevant biomarkers or physiological indicators.
03Think about how environmental or product interactions might be affected by underlying physiological conditions.

Method & Evidence

AimTo investigate the correlation between prolactin serum levels and cardiovascular risk factors, including preclinical atherosclerosis, arterial stiffening, and endothelial function, in postmenopausal women.

MethodCross-sectional study

ProcedureSerum prolactin levels were measured in 76 postmenopausal women. Correlations were examined between prolactin levels and traditional cardiovascular risk factors, as well as surrogate markers of preclinical atherosclerosis, arterial stiffening, and endothelial/microcirculatory function. Multivariate regression analysis was used to assess the independent contribution of prolactin levels.

Sample76 participants

ContextMenopausal women with cardiovascular risk factors

Variables

IVProlactin serum levels

DV["Arterial blood pressure","Central aortic systolic and diastolic blood pressures","Pulse wave velocity (aortic stiffness)","European Society of Cardiology HeartScore"]

CV["Age","Menopausal status","Traditional cardiovascular risk factors (e.g., smoking, diabetes, cholesterol levels - though the study specifically looked at independence from these)","Endothelial function markers","Microcirculatory function markers","Carotid intima-media thickness"]

Strengths & Limitations

Strengths

+Investigated a novel potential cardiovascular risk factor (prolactin) in a specific population.
+Used multivariate analysis to control for traditional risk factors, strengthening the claim of prolactin's independent association.
+Included multiple markers of cardiovascular health.

Limitations

The study's cross-sectional nature means it can't prove prolactin *causes* arterial stiffness. The sample size is relatively small, and the findings might not apply to all postmenopausal women, especially those with pre-existing conditions not studied here.

Reliability & validity

The study used immunoassay for prolactin measurement, which is a standard method. The use of multiple markers for atherosclerosis and arterial stiffness enhances the validity of the findings. However, as a cross-sectional study, it has inherent limitations in establishing causality, impacting the strength of its predictive validity for future events.

Think critically

Given that prolactin's role in cardiovascular risk is still being investigated, how might designers ethically and practically incorporate this knowledge into product development without overstating its significance or causing undue user anxiety?

Design Principles

"Design for physiological variability: Acknowledge and accommodate physiological changes associated with life stages and hormonal fluctuations when designing products and systems."

This research highlights a potential physiological factor that designers and engineers should consider when developing products or environments for aging populations, particularly women. Understanding how hormonal changes can influence physiological responses like arterial stiffness can inform the design of health monitoring devices, rehabilitation equipment, or even lifestyle interventions.

What This Means for Your Design

This study found that higher levels of the hormone prolactin in menopausal women are linked to stiffer blood vessels and higher blood pressure, even if they don't have other common heart disease risk factors. This suggests prolactin might be an overlooked factor in heart health for this group.

How to use in your project

1.Cite this research to support the need for considering specific physiological factors in your user research, especially if your design targets a demographic experiencing hormonal changes.
2.Use the findings to justify the inclusion or exclusion of certain features or design considerations based on potential physiological impacts.

Add to My Project

Quick Cite

Paragraph starter

Research indicates that physiological factors, such as elevated prolactin levels, can significantly impact cardiovascular health in postmenopausal women by contributing to arterial stiffness and increased blood pressure, independent of traditional risk factors. This underscores the importance of considering a holistic view of user physiology, including hormonal influences, when developing design solutions for this demographic, as these factors can affect user response and product efficacy.

Source

Hypertension

Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors

journal · 2009

View source

Questions About This Research

What does the research say about elevated prolactin levels correlate with increased arterial stiffness in postmenopausal women?: When designing for postmenopausal women, consider that hormonal changes can impact physiological parameters like blood pressure and arterial stiffness, potentially influencing user responses to products and environments. Evidence: Hypertension (2009).
Why does "Elevated Prolactin Levels Correlate with Increased Arterial Stiffness in Postmenopausal Women" matter for design?: This research highlights a potential physiological factor that designers and engineers should consider when developing products or environments for aging populations, particularly women. Understanding how hormonal changes can influence physiological responses like arterial stiffness can inform the design of health monitoring devices, rehabilitation equipment, or even lifestyle interventions.
How can designers apply this research?: When designing for postmenopausal women, consider that hormonal changes can impact physiological parameters like blood pressure and arterial stiffness, potentially influencing user responses to products and environments.
What were the main findings?: Positive correlations were found between prolactin serum levels and arterial blood pressure, central aortic systolic and diastolic blood pressures, and pulse wave velocity (a marker of aortic stiffness).. Prolactin levels independently predicted blood pressures and aortic stiffness, even after accounting for traditional risk factors.. Prolactin levels correlated with the European Society of Cardiology HeartScore, a composite index predicting 10-year cardiovascular mortality.. No correlation was observed with endothelial or microcirculatory function or carotid intima-media thickness.
What research method was used?: Cross-sectional study with 76 participants.
How strong is the evidence?: Evidence strength is rated Moderate effect, based on a 2009 journal from Hypertension.
What should I do differently in my next project?: When designing health-related technologies or interventions for women in or past menopause, consider how factors like prolactin levels might influence user health outcomes and product efficacy.
What are the limitations?: The study is cross-sectional, meaning it cannot establish causality. The findings are specific to postmenopausal women and may not generalize to other populations. The study did not examine all potential cardiovascular risk factors or markers of atherosclerosis.